Retraction: Stochastic induction of persister cells by HipA through (p)ppGpp-mediated activation of mRNA endonucleases (Proceedings of the National Academy of Sciences of the United States of America (2015) 112 (5171–5176) DOI: 10.1073/pnas.1423536112);Stochastic induction of persister cells by HipA through (p)ppGpp-mediated activation of mRNA endonucleases

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 16, 2015, Pages 5171-5176

  Germain, Elsa ^a,b   Roghanian, Mohammad ^a,b   Gerdes, Kenn ^a,b   Maisonneuve, Etienne ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

(p)ppGpp; Bacterial persistence; HipA; Single cell analysis; Toxin antitoxin

Indexed keywords

ANTITOXIN; BACTERIAL PROTEIN; ENDONUCLEASE; ENDOPEPTIDASE LA; GUANOSINE PHOSPHATE; MESSENGER RNA ENDONUCLEASE; PENTA GUANOSINE PHOSPHATE; PROTEIN HIPA; PROTEIN MAZF; PROTEIN RELE; PROTEIN YAFO; UNCLASSIFIED DRUG; BACTERIAL TOXIN; ESCHERICHIA COLI PROTEIN; GUANOSINE 3' DIPHOSPHATE 5' DIPHOSPHATE; GUANOSINE 3' DIPHOSPHATE 5' TRIPHOSPHATE; HIPA PROTEIN, E COLI; MESSENGER RNA;

ALLELE; ARTICLE; BACTERIAL GENE; ESCHERICHIA COLI; HIPBA GENE; NONHUMAN; PRIORITY JOURNAL; CHEMICAL STRUCTURE; ENZYME ACTIVATION; METABOLISM; STATISTICS; TIME LAPSE IMAGING;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

ALLELES; ANTITOXINS; BACTERIAL TOXINS; ENDONUCLEASES; ENZYME ACTIVATION; ESCHERICHIA COLI PROTEINS; GUANOSINE PENTAPHOSPHATE; GUANOSINE TETRAPHOSPHATE; MODELS, MOLECULAR; RNA, MESSENGER; STOCHASTIC PROCESSES; TIME-LAPSE IMAGING;

EID: 84928326779     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1906160116     Document Type: Erratum

References (47)

1. Bigger JW (1944) Treatment of staphyloccal infections with penicillin by intermittent sterilisation. Lancet 244(6320):497-500.
2. Levin BR, Rozen DE (2006) Non-inherited antibiotic resistance. Nat Rev Microbiol 4(7):556-562.
3. Allison KR, Brynildsen MP, Collins JJ (2011) Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473(7346):216-220.
4. Lafleur MD, Qi Q, Lewis K (2010) Patients with long-term oral carriage harbor highpersister mutants of Candida albicans. Antimicrob Agents Chemother 54(1):39-44.
5. Lewis K (2007) Persister cells, dormancy and infectious disease. Nat Rev Microbiol 5(1):48-56.
6. Mulcahy LR, Burns JL, Lory S, Lewis K (2010) Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol 192(23):6191-6199.
7. Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S (2004) Bacterial persistence as a phenotypic switch. Science 305(5690):1622-1625.
8. Maisonneuve E, Castro-Camargo M, Gerdes K (2013) (p)ppGpp controls bacterial persistence by stochastic induction of toxin-antitoxin activity. Cell 154(5):1140-1150.
9. Losick R, Desplan C (2008) Stochasticity and cell fate. Science 320(5872):65-68.
10. Veening JW, Smits WK, Kuipers OP (2008) Bistability, epigenetics, and bet-hedging in bacteria. Annu Rev Microbiol 62:193-210.
11. Kussell E, Leibler S (2005) Phenotypic diversity, population growth, and information in fluctuating environments. Science 309(5743):2075-2078.
12. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K (2004) Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 230(1):13-18.
13. Moyed HS, Bertrand KP (1983) hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol 155(2):768-775.
14. Korch SB, Henderson TA, Hill TM (2003) Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p)ppGpp synthesis. Mol Microbiol 50(4):1199-1213.
15. Korch SB, Hill TM (2006) Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: Effects on macromolecular synthesis and persister formation. J Bacteriol 188(11):3826-3836.
16. Rotem E, et al. (2010) Regulation of phenotypic variability by a threshold-based mechanism underlies bacterial persistence. Proc Natl Acad Sci USA 107(28):12541-12546.
17. Schumacher MA, et al. (2009) Molecular mechanisms of HipA-mediated multidrug tolerance and its neutralization by HipB. Science 323(5912):396-401.
18. Dörr T, Vulić M, Lewis K (2010) Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol 8(2):e1000317.
19. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K (2004) Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol 186(24):8172-8180.
20. Maisonneuve E, Shakespeare LJ, Jørgensen MG, Gerdes K (2011) Bacterial persistence by RNA endonucleases. Proc Natl Acad Sci USA 108(32):13206-13211.
21. Shah D, et al. (2006) Persisters: A distinct physiological state of E. coli. BMC Microbiol 6:53.
22. Vázquez-Laslop N, Lee H, Neyfakh AA (2006) Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins. J Bacteriol 188(10):3494-3497.
23. Kim Y, Wood TK (2010) Toxins Hha and CspD and small RNA regulator Hfq are involved in persister cell formation through MqsR in Escherichia coli. Biochem Biophys Res Commun 391(1):209-213.
24. Correia FF, et al. (2006) Kinase activity of overexpressed HipA is required for growth arrest and multidrug tolerance in Escherichia coli. J Bacteriol 188(24):8360-8367.
25. Pedersen K, Christensen SK, Gerdes K (2002) Rapid induction and reversal of a bacteriostatic condition by controlled expression of toxins and antitoxins. Mol Microbiol 45(2):501-510.
26. Christensen-Dalsgaard M, Jørgensen MG, Gerdes K (2010) Three new RelE-homologous mRNA interferases of Escherichia coli differentially induced by environmental stresses. Mol Microbiol 75(2):333-348.
27. Germain E, Castro-Roa D, Zenkin N, Gerdes K (2013) Molecular mechanism of bacterial persistence by HipA. Mol Cell 52(2):248-254.
28. Kaspy I, et al. (2013) HipA-mediated antibiotic persistence via phosphorylation of the glutamyl-tRNA-synthetase. Nat Commun 4:3001.
29. Maisonneuve E, Gerdes K (2014) Molecular mechanisms underlying bacterial persisters. Cell 157(3):539-548.
30. Kuroda A, Murphy H, Cashel M, Kornberg A (1997) Guanosine tetra- and pentaphosphate promote accumulation of inorganic polyphosphate in Escherichia coli. J Biol Chem 272(34):21240-21243.
31. Bokinsky G, et al. (2013) HipA-triggered growth arrest and β-lactam tolerance in Escherichia coli are mediated by RelA-dependent ppGpp synthesis. J Bacteriol 195(14):3173-3182.
32. Christensen SK, Gerdes K (2003) RelE toxins from bacteria and Archaea cleave mRNAs on translating ribosomes, which are rescued by tmRNA. Mol Microbiol 48(5):1389-1400.
33. Zhang Y, et al. (2003) MazF cleaves cellular mRNAs specifically at ACA to block protein synthesis in Escherichia coli. Mol Cell 12(4):913-923.
34. Paul BJ, et al. (2004) DksA: A critical component of the transcription initiation machinery that potentiates the regulation of rRNA promoters by ppGpp and the initiating NTP. Cell 118(3):311-322.
35. Lemke JJ, Durfee T, Gourse RL (2009) DksA and ppGpp directly regulate transcription of the Escherichia coli flagellar cascade. Mol Microbiol 74(6):1368-1379.
36. Lemke JJ, et al. (2011) Direct regulation of Escherichia coli ribosomal protein promoters by the transcription factors ppGpp and DksA. Proc Natl Acad Sci USA 108(14):5712-5717.
37. Lewis K (2010) Persister cells. Annu Rev Microbiol 64:357-372.
38. Tuomanen E, Cozens R, Tosch W, Zak O, Tomasz A (1986) The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. J Gen Microbiol 132(5):1297-1304.
39. Orman MA, BrynildsenMP (2013) Establishment of a method to rapidly assay bacterial persister metabolism. Antimicrob Agents Chemother 57(9):4398-4409.
40. Schumacher MA, et al. (2012) Role of unusual P loop ejection and autophosphorylation in HipA-mediated persistence and multidrug tolerance. Cell Reports 2(3):518-525.
41. Wen Y, et al. (2014) The bacterial antitoxin HipB establishes a ternary complex with operator DNA and phosphorylated toxin HipA to regulate bacterial persistence. Nucleic Acids Res 42(15):10134-10147.
42. Amato SM, Orman MA, BrynildsenMP (2013) Metabolic control of persister formation in Escherichia coli. Mol Cell 50(4):475-487.
43. Amato SM, Brynildsen MP (2014) Nutrient transitions are a source of persisters in Escherichia coli biofilms. PLoS ONE 9(3):e93110.
44. Gummesson B, Lovmar M, Nyström T (2013) A proximal promoter element required for positive transcriptional control by guanosine tetraphosphate and DksA protein during the stringent response. J Biol Chem 288(29):21055-21064.
45. Kajitani M, Ishihama A (1984) Promoter selectivity of Escherichia coli RNA polymerase. Differential stringent control of the multiple promoters from ribosomal RNA and protein operons. J Biol Chem 259(3):1951-1957.
46. Cashel M (1994) Detection of (p)ppGpp accumulation patterns in Escherichia coli mutants. Methods in Molecular Genetics 3:341-356.
47. Shyp V, et al. (2012) Positive allosteric feedback regulation of the stringent response enzyme RelA by its product. EMBO Rep 13(9):835-839.